Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Diagnosis (cancer. Found 6 abstracts

Cairns PG. Methods for detecting hypermethylated promoters of tumor suppressor genes associated with ovarian cancer using methylation-specific PCR. 2006 Sep 14;:28 pp.
Yuan Q, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP. Development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Molecular Cancer Therapeutics. 2006 Jan;5(8):2096-105.
Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
Adams GP, Horak EM, Weiner LM, Marks JD. Bispecific scFv antibody molecules capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer. 2004 Apr 04;:57 pp.
Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Research. 2003 Jan;63(24):8695-9.
Adams GP, Schier R. Developing anti-HER2/neu single-chain Fv fragments from phage display libraries. Methods in Molecular Medicine. 2000 Jan;39(Ovarian Cancer):729-47.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Diagnosis (cancer

Diagnosis (cancer Human Ovary Antitumor agents Cosmids Blood plasma Bacteriophage Imaging (tumor Radionuclides Mammary gland Prostate gland fusion products with Muellerian inhibiting substance type II receptor domain Kidney Ascitic fluid neu single-chain Fv fragments development from phage display libraries for use in diagnosis and therapy of cancer) BSU (Biological study Gene Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (for antibody anti-HER2 DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (APC Epitopes unclassified) neu Role: BSU (Biological study-BIOL (Biological study) (anti-HER2 Phage display library (anti-HER2 unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Urine treatment of Carcinoma (cervix Protein motifs (development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor) Signal transduction (inhibitors Neoplasm (diagnosis unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (anti-MISIIR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (momordins-antibody conjugated with promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients for early diagnosis and prognosis) unclassified) Cyclin dependent kinase inhibitors Role: BSU (Biological study-BIOL (Biological study) (p16INK4A unclassified) Gene Role: BSU (Biological study-DGN (Diagnostic use)-PRP (Properties)-BIOL (Biological study)-USES (Uses) (APC unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-Muellerian inhibiting substance type II Plasmids BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (IgG1-Fc domain Intestine (colon unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (VHL (von Hippel-Lindau) Drug delivery systems (carriers Gene therapy DGN (Diagnostic use) Genetic element Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (CpG island hypermethylation promoter tumor suppressor genes ovarian cancer PCR diagnosis Phage display library Imaging (NMR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (PAP (pokeweed antiviral protein)-antibody conjugated with DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (CDKN2A unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with promoter hypermethylation gene kidney cancer diagnosis BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (fragments-scFv anti-Mullerian inhibiting substance type II recep DGN (Diagnostic use) Promoter Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (methods for detecting hypermethylated promoters of tumor suppressor genes assocd with ovarian cancer using methylation-specific PCR) Blood serum (anal Viral vectors Blood cell Drug delivery systems (immunoconjugates Urine (promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients for early diagnosis and prognosis) Lung anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-scFv DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (DAP-kinase Ovary (carcinoma unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with fusion products with scFv Salivary gland Pancreas Adoptive immunotherapy Ricins Protein sequences bispecific antibody scFv EGFR family member cancer diagnosis therapy unclassified) APC protein Role: BSU (Biological study-DGN (Diagnostic use)-BIOL (Biological study)-USES (Uses) (promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients for early diagnosis and prognosis) Epidermal growth factor receptors Ligands Prognosis Scintigraphy unclassified) Growth factor receptors Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (erbB-3 Imaging agents cDNA sequences (anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Gene Role: BSU (Biological study-PRP (Properties)-BIOL (Biological study) (TIMP-3 site lacking Post-translational processing (proteolytic BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (bispecific unclassified) Toxins Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (cytotoxins Genetic vectors Liposomes Peptide nucleic acids bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) antibody conjugated with Drug delivery systems (prodrugs Lung (toxicity DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (RASSF1A methylation specific PCR ovary cancer diagnosis Plasmid vectors unclassified) Gene Role: BSU (Biological study-PRP (Properties)-BIOL (Biological study) (CDKN2A Chemotherapy (antibody conjugated with Blood analysis BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (bispecific scFv antibody Imaging agents (NMR contrast unclassified) DNA Role: BSU (Biological study-BIOL (Biological study) (hypermethylation Drug delivery systems (liposomes except adverse) Antibodies Role: BAC (Biological activity or effector-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv Labels Abrins unclassified) Gene Role: BSU (Biological study-DGN (Diagnostic use)-PRP (Properties)-BIOL (Biological study)-USES (Uses) (p14ARF Viral vectors (bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) Diagnosis (immunodiagnosis DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (tumor suppressor Muellerian inhibiting substance receptor antibody ovary cancer targeting of EGFR protein family for diagnosis and treatment of cancer) DNA sequences Biomarkers Methylation Tumor markers (methods for detecting hypermethylated promoters of tumor suppressor genes assocd with ovarian cancer using methylation-specific PCR) Testis Positron-emission tomography Drugs Linking agents carcinoma Uterus (cervix-treatment of DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (p14ARF Fusion proteins Cytotoxic agents magnetic Spheres (beads-antibody conjugated with Test kits (diagnostic Gamma ray (emitters or (MISIIR) immunoconjugates to detect and treat cancer) Samples (biol or biopsy unclassified) Proteins Role: BSU (Biological study-DGN (Diagnostic use)-BIOL (Biological study)-USES (Uses) (p14ARF Carcinoma (ovarian Molecules (effector Uterus (endometrium Stomach Molecular cloning Uterus (cervix Tumor markers Gel electrophoresis (non denaturing PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR Chemotherapy Drug targets unclassified) Proteins Role: BSU (Biological study-DGN (Diagnostic use)-BIOL (Biological study)-USES (Uses) (gene RASSF1A (Ras assocn domain family 1 isoform A) Animal cell HER2 neu single chain antibody phage display library review unclassified) Gene Role: BSU (Biological study-DGN (Diagnostic use)-PRP (Properties)-BIOL (Biological study)-USES (Uses) (RASSF1A unclassified) Promoter Role: BSU (Biological study-BIOL (Biological study) (promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients for early diagnosis and prognosis) unclassified) Gene Role: BSU (Biological study-PRP (Properties)-BIOL (Biological study) (VHL Radiation (external beam methods for detecting hypermethylated promoters of tumor suppressor genes assocd with ovarian cancer using methylation-specific PCR) unclassified) Peptides Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (linker mullerian inhibiting substance receptor MISIIR immunoconjugate human cancer Animal tissue development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor) Blood Immunoassay (immunohistochem BSU (Biological study Fusion proteins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (Ig Fc domain-Muellerian inhibiting substance type II receptor domain
Last updated on Tuesday, July 07, 2020